Inventor · disambiguated record
Markus Hanner
Also filed as: HANNER MARKUS
19 granted patents·11 pending applications·157 citations·filing 2004–2022
94Inventor score
Top patents by PatentIndex Score
30 records- 0193US11208439B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2018·Granted Dec 28, 2021·6 cites·19 claims
- 0293US9926343B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2016·Granted Mar 27, 2018·10 cites·18 claims
- 0392US12195501B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2021·Granted Jan 14, 2025·1 cites·23 claims
- 0492US8372411B2S. pneumoniae antigensINTERCELL AG·Filed 2009·Granted Feb 12, 2013·19 cites·30 claims
- 0592US7438912B2S.agalactiae antigens I + IIINTERCELL AG·Filed 2004·Granted Oct 21, 2008·46 cites·7 claims
- 0691US11466058B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2019·Granted Oct 11, 2022·4 cites·10 claims
- 0791US10544194B2Mutant fragments of OspA and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2016·Granted Jan 28, 2020·8 cites·9 claims
- 0891US7635487B2S. pneumoniae antigensINTERCELL AG·Filed 2004·Granted Dec 22, 2009·29 cites·16 claims
- 0989US8986704B2Mutant fragments of OspA and methods and uses relating theretoINTERCELL AUSTRIA AG·Filed 2013·Granted Mar 24, 2015·18 cites·12 claims
- 1083US7927607B2S. agalactiae antigens I and IIINTERCELL AG·Filed 2008·Granted Apr 19, 2011·5 cites·10 claims
- 1182US8449892B2S. agalactiae antigens I and IIMEINKE ANDREAS·Filed 2011·Granted May 28, 2013·5 cites·32 claims
- 1282US2023295245A1Mutant fragments of ospa and methods and uses relating theretoVALNEVA AUSTRIA GMBH·Filed 2022·Application pending·0 cites
- 1373US8236326B2Klebsiella antigensBAKSHI SHARMILA·Filed 2008·Granted Aug 7, 2012·2 cites·11 claims
- 1472US8617574B2Nontypable Haemophilus influenzae antigensVON GABAIN ALEXANDER·Filed 2010·Granted Dec 31, 2013·4 cites·8 claims
- 1563US2024026412A1Improved methods of producing a lipidated proteinVALNEVA AUSTRIA GMBH·Filed 2021·Application pending·0 cites
- 1662US2015232517A1MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETOVALNEVA AUSTRIA GMBH·Filed 2013·Application pending·0 cites
- 1761US8241643B2Peptides protective against S. pneumoniae and compositions, methods and uses relating theretoMEINKE ANDREAS·Filed 2009·Granted Aug 14, 2012·0 cites·17 claims
- 1860US8952135B2S. agalactiae antigens I and IIVALNEVA AUSTRIA GMBH·Filed 2013·Granted Feb 10, 2015·0 cites·11 claims
- 1958US8431128B2Enterococcus antigensMEINKE ANDREAS·Filed 2011·Granted Apr 30, 2013·0 cites·8 claims
- 2058US2013287782A1Enterococcus antigensMEINKE ANDREAS·Filed 2013·Application pending·0 cites
- 2157US2015250865A1MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETOVALNEVA AUSTRIA GMBH·Filed 2015·Application pending·0 cites
- 2257US2008175856A1Enterococcus AntigensINTERCELL AG·Filed 2004·Application pending·0 cites
- 2356US8529910B2Enterococcus antigensMEINKE ANDREAS·Filed 2011·Granted Sep 10, 2013·0 cites·18 claims
- 2454US8637052B2Klebsiella antigensBAKSHI SHARMILA·Filed 2012·Granted Jan 28, 2014·0 cites·80 claims
- 2553US2013136761A1S. pneumoniae antigensINTERCELL AG·Filed 2013·Application pending·0 cites
- 2652US8445001B2Peptides protective against S. pneumoniae and compositions, methods and uses relating theretoMEINKE ANDREAS·Filed 2012·Granted May 21, 2013·0 cites·17 claims
- 2750US2013280288A1Peptides protective against s. pneumoniae and compositions, methods and uses relating theretoINTERCELL AG·Filed 2013·Application pending·0 cites
- 2841US2010047263A1Peptides protective against s. pneumoniae and compositions, methods and uses relating theretoINTERCELL AG·Filed 2007·Application pending·0 cites
- 2934US2013243779A1Peptides protective against e. faecalis, methods and uses relating theretoNAGY ESZTER·Filed 2010·Application pending·0 cites
- 3024US2012141487A1Moraxella catarrhalis antigensVON GABAIN ALEXANDER·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →